Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuropathic Determining Factors and Analgesic Efficacy of Capsaicin 8% (QUTENZA®) Patches in Refractory Coccygodygnia

NCT05983263 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05983263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05983263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuropathic Determining Factors and Analgesic Efficacy of Capsaicin 8% (QUTENZA®) Patches in Refractory Coccygodygnia
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Recruiting
Start date
November 8, 2023
Completion date
June 8, 2027
Enrollment
106 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coccyx disorder